Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy

NCT03072082 is registered in ClinicalTrials.gov with Jun Li as lead sponsor.

NCT NCT03072082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine Therapy
Lead sponsor
Jun Li
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2017
Completion date
February 28, 2019
Enrollment
440 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease(cad)